Portfolio comparison
Novartis AG vs Immatics Biotechnologies
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Top Patents2 enriched
US 10472419· 2019
How Novartis Engineered Antibodies to Block the TIM-3 Immune Checkpoint
US 7740842· 2010
How to Keep High-Concentration Antibody Medicines Stable in Liquid Form
Activity by Decade
2010s2
Company B
Immatics Biotechnologies
Patents indexed
7
Year range
2019 – 2024
Most recent
2024
biotechpharmaceuticalimmunotherapyoncologygene_editing
Top Patents7 enriched
US 11407807· 2022
Using Specific Immune Cells to Fight Cancers Like Lung and Breast Cancer
US 10377797· 2019
Training Immune Cells to Fight Cancer Using Specific Markers
US 10314897· 2019
How a Specific Protein Fragment Can Train Immune Cells to Fight Cancer
Activity by Decade
2010s3
2020s4
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.